Company intelligence / Profile preview

Parasym

London, England, United Kingdomparasym.co ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Parasym’s lead product Nurosym has demonstrated rapid increases in parasympathetic activity and significant reductions in inflammation. Clinical trials have shown a 78% decrease in inflammation among heart failure patients during short hospital stays. Randomized controlled trials support efficacy for autonomic nervous system modulation and improvement of quality of life metrics. The company has completed over 3 million treatment sessions globally and collaborates with leading academic institutions such as Harvard and UCL.

Therapeutic areas: ImmunologyOtherPsychiatryCardiovascularNeurology
Modalities: DeviceNon-pharmacological therapy (specifically neuromodulation via bioelectrical signals)
Industry: Therapeutic Medical Devices

Partnerships

Academic partnerships with Harvard University and University College London (UCL)Over 60 clinical partnerships across four continents

Beyond the preview

Go deeper on Parasym.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parasym.

Explore the full profile